The nation's economy expanded more than expected in the second quarter to lift the markets to a higher close with the Dow gaining 40 points to 22,381. Nasdaq held steady at 6,453.
On the upside
Shares of Roku (Nasdaq: ROKU) rocketed on its first trading day.
Zynerba Pharmaceuticals (Nasdaq: ZYNE) reported positive results from a Phase 2 FAB-C clinical trial of ZYN002 cannabidiol gel in children with Fragile X syndrome.
Dassault Systems will pay a premium of approximately $400 million to acquire Exa (Nasdaq: EXA).
On the downside
A Seeking Alpha article noted that the majority of Health Insurance Innovations' (Nasdaq: HIIQ) brokers engaged in questionable practices and the company may be under investigation.
Shares of Veritone (Nasdaq: VERI) extended its losses.
Comtech Telecommunications (Nasdaq: CMTL) reported lower fourth quarter earnings and forecast lower fiscal 2018 earnings.
In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 2 on the NYSE and by more than 4 to 3 on Nasdaq. The broader S&P 500 added 3 points to 2,510. Bitcoin tumbled $34 to $4,165.